mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.01 |
mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.01 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.01 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |